ORBIMED ADVISORS LLC

Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned: 3,525,650 shares
Security Ownership %: 2.1%

Shares, Excluding Options vs Price

Value, Excluding Options

OrbiMed Advisors LLC ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

17 Feb 2026 - OrbiMed Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,525,650 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 2.1% ownership of the company. In their previous filing dated 14 Aug 2025, ORBIMED ADVISORS LLC had reported owning 8,461,500 shares, indicating a decrease of +58%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
OrbiMed Advisors LLC	2.1%	-66%	$15,160,295	3,525,650	-4,935,850	-58%	$4.30	13G/A	31 Dec 2025	17 Feb 2026, 18:23
OrbiMed Advisors LLC	5.4%		$20,984,520	8,461,500			$2.48	13G	30 Jun 2025	14 Aug 2025, 18:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.32%	-0.45%	$15,019,269	3,525,650	-4,935,850	-58%	$4.26	Q4 2025
30 Sep 2025	0.65%	0%	$26,992,185	8,461,500	0		$3.19	Q3 2025
30 Jun 2025	0.48%	+0.48%	$19,207,605	8,461,500	+8,461,500	NEW	$2.27	Q2 2025
30 Jun 2024		-0.15%	$0	0	-3,544,578	-100%	$5.43	Q2 2024
31 Mar 2024	0.15%	+0.15%	$7,727,180	3,544,578	+3,544,578	NEW	$2.18	Q1 2024
30 Sep 2022		-0.08%	$0	0	-2,124,975	-100%	$5.43	Q3 2022
30 Jun 2022	0.08%	0%	$3,889,000	2,124,975	0		$1.83	Q2 2022
31 Mar 2022	0.09%	-0.05%	$5,674,000	2,124,975	-1,089,534	-34%	$2.67	Q1 2022
31 Dec 2021	0.18%	+0.08%	$13,919,000	3,214,509	+1,392,641	+76%	$4.33	Q4 2021
30 Sep 2021	0.11%	+0.02%	$9,273,000	1,821,868	+308,700	+20%	$5.09	Q3 2021
30 Jun 2021	0.1%	+0.1%	$9,578,000	1,513,168	+1,513,168	NEW	$6.33	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.